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Light exposure elicits numerous effects on human physiology and behavior, such as better cognitive performance and
mood. Here we investigated the role of morning light exposure as a countermeasure for impaired cognitive
performance and mood under sleep restriction (SR). Seventeen participants took part of a 48h laboratory protocol,
during which three different light settings (separated by 2wks) were administered each morning after two 6-h sleep
restriction nights: a blue monochromatic LED (light-emitting diode) light condition (BL; 100 lux at 470 nm for 20min)
starting 2 h after scheduled wake-up time, a dawn-simulating light (DsL) starting 30min before and ending 20min
after scheduled wake-up time (polychromatic light gradually increasing from 0 to 250 lux), and a dim light (DL)
condition for 2 h beginning upon scheduled wake time (58 lux). Cognitive tasks were performed every 2 h during
scheduled wakefulness, and questionnaires were administered hourly to assess subjective sleepiness, mood, and well-
being. Salivary melatonin and cortisol were collected throughout scheduled wakefulness in regular intervals, and the
effects on melatonin were measured after only one light pulse. Following the first SR, analysis of the time course of
cognitive performance during scheduled wakefulness indicated a decrease following DL, whereas it remained stable
following BL and significantly improved after DsL. Cognitive performance levels during the second day after SR were
not significantly affected by the different light conditions. However, after both SR nights, mood and well-being were
significantly enhanced after exposure to morning DsL compared with DL and BL. Melatonin onset occurred earlier
after morning BL exposure, than after morning DsL and DL, whereas salivary cortisol levels were higher at wake-up
time after DsL compared with BL and DL. Our data indicate that exposure to an artificial morning dawn simulation
light improves subjective well-being, mood, and cognitive performance, as compared with DL and BL, with minimal
impact on circadian phase. Thus, DsL may provide an effective strategy for enhancing cognitive performance, well-
being, and mood under mild sleep restriction.
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INTRODUCTION
Light exerts powerful non-image-forming (NIF) effects
on behavioral and physiological functions, including
hormonal secretion (Cajochen, 2005; Jung et al., 2010),
sleep-wake regulation (for a review, see Chellappa et al.,
2011a), cognitive function (Cajochen et al., 2011;
Chellappa et al., 2011b), and its underlying cerebral
correlates, encompassing cortical and subcortical brain
regions (Vandewalle et al., 2009b). These light-depen-
dent effects are to a large extent mediated by retinal
photoreceptors containing the photopigment melanop-
sin, which are distinct from rods and cones (Hattar et al.,
2002). Maximal sensitivity of the human alerting
response and melatonin suppression to light occurs at
the short-wavelength light (ca. 460–480 nm), contrasting
with the spectral sensitivity of classical visual photo-
receptors (green light,5550 nm) (Cajochen et al., 2005;
Lockley et al., 2006; Mu¨nch et al., 2006; Revell et al.,
2006). Together with light’s wavelength, other proper-
ties, such as intensity, duration, and timing, are crucial
in determining its effects on human physiology and
behavior (for a review, see Cajochen, 2007). Nighttime
light exposure triggers melatonin suppression with
concomitant reduction of subjective sleepiness and
objective markers of sleepiness (e.g., waking electro-
encephalographic [EEG] theta activity, incidence of slow
eye movements) (Cajochen et al., 2000; Chellappa et al.,
2011b, 2012; Lockley et al., 2006; Ruger et al., 2005).
It has been suggested that these effects are mediated
through melatonin’s alerting effects and/or its resetting
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properties on the endogenous circadian pacemaker
(Chellappa et al., 2011a). Although the studies investi-
gating the impact of daytime light are less abundant,
three studies reported that bright white light exposure
during daytime also enhances alertness (Phipps-Nelson
et al., 2003; Ruger et al., 2005; Smolders et al., 2012).
In the same vein, 20 min of daytime exposure to
bright white light (ca. 7000 lux) increases task-related
cortical activity while performing an oddball paradigm
(Vandewalle et al., 2006). Bright white light sources are
used as a therapeutic countermeasure against circadian
rhythm sleep disorders (Zhu & Zee, 2012) and depres-
sion, particularly seasonal depressive disorder (Wirz-
Justice et al., 1986). Apart from its therapeutic use,
bright light also improves well-being, vitality, and mood
stability among healthy subjects working indoors in
wintertime (Partonen & Lonnqvist, 2000). Furthermore,
chronic daytime exposure to blue-enriched moderate-
intensity light has the potential to improve visual
comfort, alertness, sleepiness, and mood in the working
environment (Viola et al., 2008).
More recently, the dynamics of light exposure have
been shown to directly affect the impact of morning
light exposure on sleep inertia, well-being, and cortisol
levels (Gimenez et al., 2010; Van de Werken et al., 2010).
The use of an artificial dawn light resulted in a
significant reduction of sleep inertia complaints, which
could not be explained by a shift in the dim light
melatonin onset or timing of sleep offset (Gimenez et al.,
2010). In another study, Van de Werken et al. (2010)
showed that 30 min of an artificial dawn light (max-
imum 300 lux) prior to wake-up time was more efficient
in alleviating sleep inertia and increasing subjective
alertness compared to acute light exposure (300 lux) at
wake-up time. However, they could not find significant
effects on cognitive performance and did not confirm
enhanced cortisol levels upon awakening after dawn, as
observed earlier by Thorn et al. (2004). Although these
initial studies clearly showed beneficial effects of an
artificial dawn signal on sleep inertia and well-being, the
design of the studies did not allow for testing how these
acute effects of a dawn simulation light translate into
daytime cognitive performance and well-being levels.
To address this question, we investigated the impact
of morning artificial dawn simulation light exposure on
alertness, well-being, mood, cognitive performance, and
classical markers of the circadian timing system (mela-
tonin and cortisol) and compared this effect with a dim
light condition, as well as with a bright monochromatic
blue light exposure of fixed intensity. The duration of
light exposure during scheduled wakefulness (eyes
open) was the same for each of the two experimental
light conditions, but they differed in intensity, spectral
composition, and the timing of administration. This
latest aspect was motivated by the potential modality of
using blue light not directly in the bedroom but at the
beginning of the morning, possibly at work. One
primary aim of this was to compare two morning light
devices that are known for their effects on mood and
cognitive performance, even though they do not share
the same characteristics. The entire study protocol was
performed under stringently controlled laboratory con-
ditions, with two sleep restriction nights in order to test
whether these light effects can counteract the detri-
mental effects of partial sleep loss on daytime alertness
and cognitive performance, which is increasingly
encountered in contemporary society. We hypothesized
the following:
(1) As compared with the dim light condition, light
exposure mimicking dawn will facilitate the
wake-up process with respect to subjective per-
ception of sleepiness, tension, and well-being
and will have a beneficial impact on cognitive
performance levels, especially in the time zone
surrounding the wake-up period.
(2) As compared with the dim light condition, blue
light exposure will increase subjective and object-
ive neurobehavioral performance, which will be
potentially sustained throughout the entire
waking day.
(3) As maximal circadian phase-advancing proper-
ties have been attributed to short-wavelength
light in the morning, particularly BL will lead to a




Study volunteers were recruited through advertisements
at different local universities and internet sites in
Switzerland, Germany, and France. The screening pro-
cedure began with a telephone interview, involving a
detailed explanation of the study. All participants gave
written informed consent. The study protocol, screening
questionnaires, and consent forms were approved by
the local ethics committee (EKBB/Ethikkommission
beider Basel, Switzerland). They conformed to the
Declaration of Helsinki and were performed in accord-
ance with international ethical standards (Portaluppi
et al., 2010). All applicants completed questionnaires
about their sleep quality, life habits, and health state.
These questionnaires comprised a consent form, a
General Medical Questionnaire, the Beck Depression
Inventory II (BDI-II) (Beck et al., 1961), the Epworth
Sleepiness Scale (ESS) (Johns, 1991), the Horne-O¨stberg
Morningness-Eveningness Questionnaire (MEQ) (Horne
& O¨stberg, 1976), the Munich Chronotype Questionnaire
(MCTQ) (Roenneberg et al., 2003), and the Pittsburgh
Sleep Quality Index (PSQI). Potential candidates with a
PSQI score 45 were excluded from the study (Buysse
et al., 1989). Further exclusion criteria were smoking,
medication or drug consumption, body mass index
519 and428 kg/m2, shiftwork within the last 3 months,
transmeridian flights during the 3 months before the
study, as well as medical and sleep disorders. Since our
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study protocol included two nights of partial sleep
restriction (restriction to 6 h), we also excluded partici-
pants with usual sleep durations of 57 h and of 49 h
(Aeschbach et al., 1996), to minimize a possible con-
founding effect of sleep duration (Table 1).
One week before the study, participants were
requested to refrain from alcohol, caffeine, and choc-
olate intake in order to level out the impact of
these consumption behaviors on sleep and the other
investigated variables reported here (e.g., subjective
sleepiness). They were also instructed to keep a regular
sleep-wake schedule (bedtimes and wake times within
30 min of self-selected target time) for 1 wk prior to
each study segment. Compliance was verified by wrist
actigraphy (Actiwatch L; Cambridge Neurotechnologies,
Cambridge, UK) and self-reported sleep logs. Eighteen
young healthy men (20–33 years old; mean SEM:
23.1 0.8) who fulfilled all inclusion criteria were
selected to participate in the study. One participant
could not be included in the analysis because of poor
quality of the EEG recordings and noncompliance
during cognitive testing. The remaining 17 volunteers
had the following light treatment order: 3 DL-BL-DsL, 3
BL-DsL-DL, 3 DsL-DL-BL, 3 DL-DsL-BL, 3 BL-DL-DsL,
and 2 DsL-BL-DL; where BL is a blue monochromatic
LED (light-emitting diode) light condition (100 lux at
470 nm for 20 min) starting 2 h after scheduled wake-up
time, DsL is a dawn-simulating light starting 30 min
before and ending 20 min after scheduled wake-up time
(polychromatic light gradually increasing from 0 to
250 lux), and DL is a dim light (DL) condition for 2 h
beginning upon scheduled wake time (58 lux). Six
participants were morning (59 to 86), nine intermediate
(42 to 58), and two evening (16 to 41) chronotypes,
according to the MEQ, whereas for the MCTQ, there
were seven morning (0 to 3.99), four intermediate (4 to
4.99), and six evening (5 to 9.5) chronotypes. A com-
prehensive urine toxicological analysis for drug abuse
was carried out prior to the study, along with an
ophthalmologic examination in order to exclude
volunteers with visual impairments (visual field, color
vision, pupillary reflex).
The study was carried out during the winter season
(January to March) in Basel, Switzerland, to minimize
the effects of outdoor ambient light levels. The labora-
tory setup comprised a balanced crossover design with
three segments (one control condition and two experi-
mental conditions), separated by an at least 2-wk
intervening period. Participants remained in individual
windowless and sound-attenuated bedrooms under
controlled 40 lux light condition, except for the first 2 h
after wake-up during the morning light exposure (see
below). No information on time-of-day was given. Each
study segment lasted 48 h, comprising two sleep restric-
tion (SR) nights (6 h) adjusted to each participant’s
habitual bedtime followed by two 18-h scheduled
waking days (Figure 1A). The light protocol for each
session consisted of a 2-h dim light (58 lux) exposure
after wake-up time followed by 40 lux until bedtime. The
light treatment was administered after each sleep-
restricted night, either with no additional light for the
control condition, or with a blue light (BL; 2 h after
wake-up, 20-min exposure of 100 lux of 470 nm; full
width at half maximum [FWHM] 27 nm) with a photon
density of 2.4E 18 photons/m2  s and a melanopic
value of 4150 m-lux (goLITE BLU energy light; HF3330;
Philips, Drachten, Netherlands) placed at 50 cm diag-
onally of the participant when he was sitting at the desk
looking straight ahead (see Figure 1B for spectral
composition), or with a DsL (polychromatic light grad-
ually increasing from 0 to 250 lux during 30 min before
wake-up time; the light remained around 250 lux for
20 min after wake-up time) placed near the bed at eye
level (see Figure 1C for the time course of spectral
composition). The illuminance, photon density, corre-
lated color temperature and melanopic illuminance of
the dawn simulation light, measured 45 cm from the
device were as follows:
 5 min after light onset: 1.2 lux, 1.9E 16/m2 s,
1090 K, 0.2 m-lux
 15 min after light onset: 13 lux, 1.4E 17/m2 s,
1500 K, 7.5 m-lux
 24 min after light onset: 78 lux, 7.1E 17/m2 s,
2200 K, 120 m-lux
 30 min after light onset: 250 lux, 2.4E 18/m2 s,
2750 K, 620 m-lux
Subjective Assessment of Sleepiness, Well-being,
and Mood
Subjective sleepiness was assessed every hour, using the
Karolinska Sleepiness Scale (KSS) (Akerstedt et al., 1994).
Subjective tension was measured using a 100-mm visual
analog scale (VAS). Subjective well-being was assessed
using a composite score calculated as follows: [VAS
moodþ (100VAS tension)þ (100VAS physical com-
fort)]/3, according to Birchler-Pedross and colleagues
(Birchler-Pedross et al., 2009). Subjective mood was
investigated every 2 h on the Positive and Negative
TABLE 1. Characteristics of the group of participants.
Characteristic Minimum Maximum Mean SEM
n 17
Age 20 33 23.12 0.82
Sleep time (h) 21:45 2:00 23:50 00:19
Wake time (h) 6:00 10:00 07:57 00:15
Sleep duration (h:min) 7:00 9:00 08:06 00:08
BDI 0 7 1.47 0.51
ESS 1.5 14 5.79 1.01
MEQ 29 74 54.35 2.64
MCTQ 2.33 6.49 4.4 0.28
PSQI 1 5 2.88 0.27
BMI 20.75 25.76 22.86 0.35
BDI¼Beck Depression Inventory; ESS¼Epworth Sleepiness Scale;
MEQ¼Horne-O¨stberg Morningness-Eveningness Questionnaire;
MCTQ¼Munich Chronotype Questionnaire; PSQI¼Pittsburg
Sleep Quality Index; BMI¼body mass index.




















































Affect Scale (PANAS) (Watson et al., 1988).
This questionnaire comprises two 10-item mood
scales, and provides measures of positive affect (PA)
and negative affect (NA) on a 5-point scale.
Cognitive Performance
Beginning 30 min after wake-up time, participants
completed a 25-min test battery every 2 h. The battery
included five cognitive tasks for sustained attention and
executive functions: Sustained Attention to Response
Task (SART; Robertson et al., 1997), Verbal 1-, 2-, and 3-
back (N-Back1-2-3; Kubat-Silman et al., 2002), and
Paced Visual Serial Addition Task (PVSAT; Feinstein
et al., 1994). To quantify the magnitude of the light
effects on global cognitive performance, a composite
score was computed by normalizing the data for each
test separately (i.e., SART, PVSAT, N-Back1-2-3) and
averaging it to yield a composite score for each volun-
teer for each 2-h period according to Viola and col-
leagues (Viola et al., 2007).
Salivary Melatonin and Cortisol
Saliva samples were scheduled during wakefulness
every 30 min during the first 4 h after wake-up time
and followed by hourly intervals until bedtime,
starting the first evening upon arrival at the laboratory.
Salivary samples were immediately frozen and kept at
20 C until the melatonin and cortisol assays were
conducted. A direct double-antibody radioimmuno-
assay was used for the melatonin assay (validated
by gas chromatography–mass spectroscopy with an
analytical least detectable dose of 0.65 pm/mL;
Bu¨hlmann Laboratory, Scho¨nenbuch, Switzerland;
Weber et al., 1997). The minimum detectable dose of
melatonin (analytical sensitivity) was determined to be
2 pg/mL.
Cortisol was measured by ALPCO (ALPCO
Diagnostics, Salem, NH, USA), using a direct salivary
enzyme-linked immunosorbent assay (ELISA) for quan-
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FIGURE 1. (A) Protocol design. Three conditions with different morning light exposures. Spectral composition (light wavelength by
irradiance; W/m2-nm) of the (A) blue light and the (B) dawn simulation light at 5 min (gray solid line), 15 min (gray dash line), 24 min (black
solid line) and 30 min (black dash line).
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1.0 ng/mL and intra-assay coefficient of variances
amounts to 10.3% for baseline values 6.6 ng/mL.
Statistical Analysis
For all analysis, the statistical package SAS (version 9.1;
SAS Institute, Cary, NC, USA) was used. Statistical
analyses were carried out for each variable (subjective
sleepiness, subjective well-being, positive and negative
affects, and cognitive performance) separately with the
mixed-model analysis of variance for repeated measures
(PROC MIXED), with within factors ‘‘light condition’’
(dim light [DL] versus blue light [BL] versus dawn
simulation light [DsL]) and ‘‘time-of-day’’ (all assessed
time points). The rationale for this approach was that
time-of-day was deemed as a continuum, and thus a
better form to illustrate the temporal dynamics of all our
dependent variables. The time course of the melatonin
profiles were analyzed for each day (SR1 and SR2)
separately, since melatonin onsets were only available
for the baseline evening and in the evening after SR1.
Cortisol analysis was also done separately for SR1 and
SR2, since we intended to analyze the wake-up response
after both sleep restriction nights. Contrasts were
assessed with the LSMEANS statement, and degrees of
freedom were corrected with the Kenward-Rogers con-
trasts. The Wilcoxon-Mann-Whitney test was used for
post hoc comparisons, since not all data reached the
criterion for a normal distribution. Alpha adjustment for
multiple comparisons was applied according to Curran-
Everett (Curran-Everett, 2000).
For the analyses of the dim light melatonin onset
(DLMO) following exposure to either DL, BL, or DsL,
data were z-scored to provide a normalized comparison
of amplitudes across each individual (Zeitzer et al.,
1999). The individual z-score adjustment provides a
mean at 0 with a variation of 1. For each melatonin
profile, we derived a DLMO using a fixed threshold of 0.
The DLMO was defined as the time when melatonin
levels hit and exceeded the threshold. The time the
melatonin levels crossed the threshold was determined
by linear interpolation between the points immediately
below and above the threshold on the day following
exposure to either BL or DsL relative to melatonin onset
on the day prior to light exposure (baseline levels of
melatonin under dim light conditions) (Zeitzer et al.,
1999).
RESULTS
Subjective Assessment of Sleepiness, Well-being,
and Mood
With respect to subjective sleepiness, we observed a
significant main effect of ‘‘light condition’’ and ‘‘time-
of-day’’ (Table 2). Analysis revealed no significant
influence of light exposition on subjective sleepiness
after the first sleep restriction (SR). However, after the
second SR, participants felt subjectively sleepier follow-
ing BL exposure compared with the DsL and DL
conditions (Figure 2, first panel). Post hoc analysis
revealed a significant difference between the DsL and
the DL exposure at 10 h of elapsed time awake (ca.
16:00 h the afternoon) after the second night of sleep
restriction and between the BL and the DL exposure at
4 h of elapsed time awake (ca. 10 h the morning) after
the second night of sleep restriction (Wilcoxon non-
parametric test).
Concerning well-being, we observed a significant
main effect for the factors ‘‘light condition’’ and ‘‘time-
of-day’’ (Table 2). Furthermore, considering the light
effect, analyses revealed that the participants felt gen-
erally better during the entire study after a DsL exposure
compared to a BL or a DL exposure. Compared with the
BL exposure, well-being after the DsL improved during
approximately 7 h after the first SR night. After BL
exposure, well-being levels were maintained stable
compared with DL condition. After the second SR
night, the level of well-being was likewise increased
after a DsL exposure throughout all the day. Post hoc
analysis revealed a significant difference between the
DsL and the DL exposure at 10 and 12 h of elapsed time
awake (ca. 16:00 and 18:00 h the afternoon) after the
second night of sleep restriction (Wilcoxon non-para-
metric test) (Figure 2, second panel).
A similar profile was observed with respect to
subjective tension (main effect of ‘‘light condition’’
and ‘‘time-of-day’’; Table 2). Subjective tension was
lower after a DsL exposure compared with BL or DL
exposure across all the experiment. Post hoc analysis
revealed a significant difference between the DsL and
the DL exposure at 6, 10, and 12 h of elapsed time
awake (ca. 12:00, 16:00 and 18:00 h the afternoon) after
the second night of sleep restriction (Wilcoxon non-
parametric test) (Figure 2, third panel).
Concerning the mood scales, we observed significant
effects of ‘‘light condition’’ and ‘‘time-of-day’’ when
TABLE 2. Analysis of variance for different variables for the time course of the study.
Analysis of variance
Variable Light Time of day LightTime of day
Sleepiness F2,658¼ 4.70, p50.01 F14,658¼ 14.40, p50.0001 F28,658¼ 0.46, p¼ 0.9927
Well-being F2,658¼ 12.00, p50.0001 F14,658¼ 6.20, p50.0001 F28,658¼ 0.47, p¼ 0.9922
Tension F2,658¼ 13.20, p50.0001 F14,658¼ 3.40, p50.0001 F28,658¼ 0.53, p¼ 0.9786
Positive mood F2,702¼ 3.17, p¼ 0.0426 F14,702¼ 8.33, p50.0001 F28,702¼ 0.96, p¼ 0.5291
Negative mood F2,702¼ 8.21, p¼ 0.0003 F14,702¼ 0.44, p¼ 0.9617 F28,702¼ 0.42, p¼ 0.9965
Cognitive performance F2,658¼ 10.31, p50.0001 F14,658¼ 0.32, p¼ 0.9920 F28,658¼ 0.40, p¼ 0.9978




















































looking at the overall time course. DsL and BL exposures
helped maintaining mood after the first SR night,
whereas under the dim light condition, positive mood
was significantly lower. After the second SR night,
positive mood was equal across all light settings
(Figure 2, fourth panel). However, the post hoc analysis
did not reveal significant light effects.
For the negative mood scale, only a main effect of
‘‘light condition’’ was found. A reverse pattern was also
observed: although the light condition did not affect
negative mood after the first sleep restriction night, DsL
was able to decrease negative mood over the day follow-
ing the second sleep restriction night. Post hoc analysis
revealed a significant difference between the DsL and the
DL exposure at 10 h of elapsed time awake (ca. 16:00 h the
afternoon) after the second night of sleep restriction
(Wilcoxon non-parametric test) (Figure 2, fifth panel).
Cognitive Performance
Analysis of the composite score of cognitive per-
formance revealed a significant main effect of ‘‘light
condition’’ when looking at the overall time course.
Nevertheless, analysis did not reveal a general signifi-
cant effect concerning the light treatment. Following
the first sleep restriction night, cognitive performance
was significantly better following morning DsL exposure
compared with morning BL exposure, in which per-
formance did not differ compared to DL. After the
second SR night, these differences were no longer
significant between DsL and DL. Interestingly, cognitive
performance started on a higher level the day following
the second SR compared to the level before this SR night
under the latter light conditions, whereas levels
remained similar for the blue light condition until the
end of the protocol. Post hoc analysis revealed a
significant difference between the DsL and the DL
exposure at 16 h of elapsed time awake (ca. 22:00 h the
afternoon) after the first night of sleep restriction
(Wilcoxon non-parametric test) (Figure 3).
Salivary Melatonin
During the baseline evening, before the first SR and light
intervention, melatonin levels were equal across all
conditions. However, analysis of the melatonin profile
during the first evening after morning light exposure
yielded a significant main effect of ‘‘light condition’’
(F2,280¼ 9.3, p¼ 0.0001) and ‘‘time-of-day’’ (F6,280¼ 62.7,
p50.0001), as well as an interaction ‘‘light condition’’
versus ‘‘time-of-day’’ (F10,280¼ 2.0, p50.04). Although
melatonin levels were not affected by the DsL, neither
after the first, nor after the second SR; morning BL
exposure elicited a phase advance in salivary melatonin.
Melatonin secretion increased earlier after a BL expos-
ure than after a DsL or DL exposure (Figure 4A).
Congruently, we found a main effect of ‘‘light condi-
tion’’ (F2,27.4¼ 5.4, p¼ 0.01) for the DLMO, which was
significantly earlier after morning BL (21:20 h 19 min)
FIGURE 2. Time course (left panel) and mean of all the time points
(right panel) of (top to bottom) subjective sleepiness, subjective
well-being, tension, positive mood, and negative mood in 17
participants under dim light (dark gray lines), monochromatic blue
LEDs (black lines with white circles), or dawn simulation light
(black lines with black circles). Data are plotted as a mean for each
2-h bin relative to elapsed time (h) after wake time, and the error
bars represent the standard error of the mean. Post hoc compari-
sons were carried out using the Wilcoxon-Mann-Whitney test
between the DsL and the DL (m, p50.05) and between the BL and
the DL (D, p50.05).
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exposure compared to DL (21:50 h 23 min; p¼ 0.003)
and DsL (21:38 h 17 min; p¼ 0.05) exposure.
Salivary Cortisol
Comparable to melatonin profile, cortisol levels were
similar across sessions on the first evening, before
intervening SR and light application. After light exposure
and SR, a main effect of ‘‘light condition’’ was observed,
irrespective of whether the morning after the first
(F2,363¼ 3.3, p¼ 0.0383) or second (F2,381¼ 3.5,
p¼ 0.0317) SR night was considered. Compared to
the DL condition, cortisol levels decreased during
the first evening after 13 to 16 h of elapsed time awake
(i.e., corresponding time-of-day: 18:00 h to 22:00 h)
after a morning BL exposure but not after a DsL
exposure (F2,270¼ 8.9, p¼ 0.0002). Additionally, during
the first hour since awakening, a significant increase
in cortisol levels upon wake-up with the DsL was
observed during both mornings after SR (mean SEM:
DL¼ 20.35 1.43 ng/mL; BL¼ 22.96 1.49 ng/mL;
DsL¼ 31.99 2.13 ng/mL) compared to the two other
conditions (F2,32¼ 15.65, p50.0001) (Figure 4B).
DISCUSSION
Here we investigated whether the exposure to artificial
light sources, differing in their dynamics and spectral
sensitivity, can facilitate the waking-up process and
allow the improvement of subjective parameters of well-
being, sleepiness, and tension, as well as cognitive
performance throughout a sustained period of wakeful-
ness, following sleep restriction. Our data suggest that
morning exposure to dawn simulation light can signifi-
cantly improve subjective perception of well-being,
mood, and tension, as well as cognitive performance.
Importantly, this effect can persist up to 18 h after light
exposure. In parallel, dawn light simulation did not
change the circadian phase of cortisol and melatonin
profiles, in contrast to exposure to blue monochromatic
light-emitting diodes (LEDs). In other words, although
the light effects on classical markers of circadian phase
showed maximal sensitivity to short-wavelength light
exposure (blue monochromatic LEDs), the sustained
effects on subjective well-being, mood, tension, and
cognitive performance were mostly driven by the
exposure to a broadband polychromatic light source
simulating dawn.
The strengths of this study are the strictly controlled
laboratory conditions and the selection criteria of the
volunteers (sleep-wake times were similar for all par-
ticipants), which allowed us to carefully quantify and
analyze the effects of dawn simulation light and blue
monochromatic light in contrast to a dim light condi-
tion, and to thus conclude that our light-induced effects
were not driven exclusively by prior differences in
circadian phase and sleep pressure levels.
FIGURE 4. Time course of salivary (A) melatonin and (B) cortisol
profiles in 17 participants under dim light (dark gray lines),
monochromatic blue LEDs (black lines with white circles), or dawn
simulation light (black lines with black circles). Data are plotted as
a mean for each 2-h bin relative to elapsed time (h) after wake
time, and the error bars represent the standard error of the mean.
FIGURE 3. Time course (left panel) and mean of all the time points
(right panel) of the composite of cognitive performance in 17
participants under dim light (dark gray lines), monochromatic blue
LEDs (black lines with white circles), or dawn simulation light
(black lines with black circles). Data are plotted as a mean for each
2-h bin relative to elapsed time (h) after wake time, and the error
bars represent the standard error of the mean. Post hoc compari-
sons were carried out using the Wilcoxon-Mann-Whitney test
between the DsL and the DL (m, p50.05) and between the BL and
the DL (D, p50.05).




















































Our data are in line with previous observations
indicating that 30 min of artificial dawn light exposure
in the morning hours improves subjective well-being
during the time window of sleep inertia (Gimenez et al.,
2010). Similarly, we found that light exposure around
wake-up time counteracted the detrimental effects of
sleep inertia, resulting in higher subjective well-being,
but also in more positive (respectively less negative)
mood as assessed by a validated affect scale (PANAS).
Importantly, our data show for the first time that these
effects are sustained over a whole waking day after one
sleep-restricted night (for mood measures) and are even
still operational after two nights of partial sleep restric-
tion for subjective well-being and tension.
Beneficial effects of light on mood may be mediated
through long-term circadian effects (Avery et al., 2001;
Lewy et al., 1987). Another possible neuroanatomical
modulator for these effects is the amygdala, a key
component of the limbic system, which encompasses
brain areas related to emotion processing, with direct
projections from melanopsin-containing intrinsic
photosensitive retinal ganglion cells (ipRGCs), and is
acutely affected by light exposure (Vandewalle et al.,
2010).
Our data suggest that dawn simulation light could
induce facilitation of the wake-up process and allows a
sustained beneficial effect throughout the entire waking
day. Interestingly, the observed increase of subjective
well-being, tension, and mood was associated with
higher cortisol levels after wake-up with the dawn
simulation light, in comparison with dim light and
monochromatic blue LED exposure, which was most
likely applied too late to induce any cortisol response.
Light after wake-up (Scheer & Buijs, 1999), and espe-
cially dawn simulation light (Thorn et al., 2004), has
previously been reported to affect cortisol levels upon
awakening. Furthermore, bright light seems to trigger
maximal effects on cortisol secretion when applied
during the upward portion of cortisol secretion, i.e., in
the early morning hours, close to wake-up time (Jung
et al., 2010). It may be assumed that these increased
cortisol levels upon wake-up reflect a light-induced
stress response. However, we observed that our volun-
teers felt subjectively more relaxed after DsL exposure as
compared to BL and DL. Alternatively, and in line with
what we observed at the subjective level, DsL before and
after wake-up could facilitate the wake-up process per
se and positively affect the process of sleep inertia by
increased cortisol levels immediately after wake-up.
Such an effect might be mediated by the suprachias-
matic nuclei (SCN), which have direct multisynaptic
neural pathways to the adrenal cortex (Buijs et al., 1999).
Dawn simulation light increased cognitive perform-
ance levels over the first day after SR. This beneficial
effect was no longer maintained after the second SR
night. It may thus be assumed that artificial dawn
simulation light is beneficial for the maintenance of
cognitive performance, but only if homeostatic sleep
pressure, as challenged by SR, is not sufficiently high to
be ‘‘unresponsive’’ to light. Recent functional magnetic
resonance imaging (fMRI) studies propose a cerebral
network underlying beneficial non-image-forming
effects of light on cognition (Vandewalle et al., 2009a).
It is suggested that the light irradiance signal impinges
onto the SCN, indirectly communicating with the
brainstem locus coeruleus, which in turn presents
thalamic and cortical connections allowing modulation
over widespread cortical networks implicated in suc-
cessful cognitive performance (Vandewalle et al.,
2009b). However, little is known about the magnitude,
dynamics, and regional brain distribution of such non-
image-forming effects and how properties, such as dose,
duration, intensity, and for instance different light
dynamics impact on the above mentioned networks
(Chellappa et al., 2011a). Subcortical regions are thought
to be more promptly activated and display short-lasting
responses to light, whereas the long-lasting and wide-
spread cortical task-related brain responses appear
when light exposure is longer and at a higher intensity
(Perrin et al., 2004). It may be speculated that the
duration of light exposure, here indexed by 30 min of
gradually increasing polychromatic light exposure
(dawn simulation light) followed by 20 min of moderate
light exposure (light duration of 50 min), results in such
long-lasting optimal cognitive performance across the
day.
Spectral sensitivity of non-image-forming effects of
light on circadian physiology has repeatedly been shown
to be highest in the short-wavelength range of the visible
light spectrum (Brainard et al., 2001; Gooley et al., 2010).
In our study, we observed that a 20-min exposure
to monochromatic blue LEDs 2 h after wake-up did
not affect subjective sleepiness, tension, and cognitive
performance compared to a dim light condition.
However, we did not have a control light condition at
equal time-of-day with the same duration as compari-
son. We also did not measure during the blue light
exposure but only 40 min later for the KSS and 10 min
later for mood and cognition. Moreover, most of the
studies reporting specific spectral sensitivity of blue
light on alertness in humans administered light either
during nighttime or the evening hours (Cajochen, 2007;
Chellappa et al., 2011a), except for the fMRI study
(Vandewalle et al., 2006).
Concomitant to the absence of effects at the subject-
ive and cognitive levels after BL exposure as compared
with the DL control condition, we observed a significant
phase advance in the circadian phase markers of
melatonin and cortisol after morning blue LED expos-
ure. Our results are in line with previously observed
phase advances for melatonin after 6.5 h bright light
exposure centered after the core body temperature nadir
(Khalsa et al., 2003). Exposure to intermittent blue LED
light (three 30-min pulses over 2 h) over 3 days induced
melatonin phase shifts, such that the phase advances
extend later in the day and the phase delays start earlier
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relative to white light (Revell et al., 2012). Very recently,
a phase response curve (PRC) for short-wavelength
(monochromatic blue 480 nm) light was constructed to
assess DLMO phase shifts (Ruger et al., 2013). Exposure
to 6.5 h of 480 nm light indicated fitted maximum delays
and advances of 2.6 and 1.3 h, respectively.
Furthermore, the 6.5 h of 480 nm, 11.2 lux light PRC
resulted in approximately 75% of the response of the
6.7 h of 10 000 lux white light PRC. This capacity for blue
light (during the phase-advancing portion of the human
PRC) to significantly advance DLMO may thus explain
our earlier melatonin onset following a 20-min morning
light exposure to monochromatic blue LED relative to
DSL and DL. One likely explanation is the higher
irradiance and melanopic values in the short wave-
length, since the mechanisms involved in melatonin
suppression are mostly sensitive to this wavelength
(Brainard et al., 2001, 2008). Blue light impinges onto
the non-image-forming pathway, involving melanopsin-
containing intrinsic photosensitive retinal ganglion cells
(ipRGCs), which then modulates responses in the
ventrolateral preoptic nucleus (VLPO) and the SCN
via a specialized non-image-forming retinohypothala-
mic tract with direct neuronal connections to the
SCN (Tsai et al., 2009). Given that the SCN is directly
involved in the circadian timing system, with direct
neuronal projections to the pineal gland (central site
for melatonin production), nocturnal melatonin secre-
tion would then phase advance, as would be predicted
by the classical phase response curve of light to the
circadian system (Khalsa et al., 2003; Minors et al.,
1991).
Nevertheless, the magnitude of which our data can be
extrapolated to real-life settings should be viewed with
caution, since under those conditions, other concomi-
tant effects such as social constraint, exposure to
outdoor light, and different types of artificial lighting,
may mask, minimize, or perhaps even enhance the
effects of our current results. Future studies under real-
life settings may be required to probe the extent to
which morning light devices may impact on mood
and cognitive performance, particularly on a long-term
perspective.
CONCLUSION
Our data indicate that exposure to artificial morning
dawn simulation light improves subjective perception
of well-being and mood, as well as cognitive per-
formance, under conditions of mild sleep restriction.
Concomitantly, it did not result in phase advances of
cortisol and melatonin profiles, as induced by the
blue light, thus resulting in a minimal impact on the
circadian timing system. In a broader context, these
light conditions may provide an effective rationale for
enhancing performance and mood in individuals who
experience conditions of mild sleep restriction.
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